Page last updated: 2024-09-05

butyrylcarnitine and Cancer of Lung

butyrylcarnitine has been researched along with Cancer of Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Akrami, M; Chamoto, K; Fagarasan, S; Hatae, R; Hirai, T; Honjo, T; Kawaguchi, S; Kim, YH; Masuda, I; Matsuda, F; Okuno, Y; Ozasa, H; Sakamori, Y; Sonomura, K; Taneishi, K; Yoshida, H	1

Other Studies

1 other study(ies) available for butyrylcarnitine and Cancer of Lung

Article	Year
Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapy. JCI insight, 2020, 01-30, Volume: 5, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carnitine; Drug Therapy, Combination; Energy Metabolism; Female; Glutathione Disulfide; Hippurates; Humans; Immunotherapy; Lung Neoplasms; Male; Microbiota; Middle Aged; Nivolumab; Programmed Cell Death 1 Receptor; Prospective Studies	2020

Article

Year

Combination of host immune metabolic biomarkers for the PD-1 blockade cancer immunotherapy.

JCI insight, 2020, 01-30, Volume: 5, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carnitine; Drug Therapy, Combination; Energy Metabolism; Female; Glutathione Disulfide; Hippurates; Humans; Immunotherapy; Lung Neoplasms; Male; Microbiota; Middle Aged; Nivolumab; Programmed Cell Death 1 Receptor; Prospective Studies

2020